Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald VanDevanter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Thorax|December 2, 2021
What shall we learn from TEACH?Donald VanDevanter, John Lipuma
Thorax|February 24, 2016
Advancing clinical development pathways for new CFTR modulators in cystic fibrosisNicole Mayer-Hamblett, Michael Boyle, Donald VanDevanter
Seminars in Respiratory and Critical Care Medicine|December 31, 2019
Cystic Fibrosis: Advances in Understanding and TreatmentPatrick A Flume, Christopher H Goss, Donald VanDevanter
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2019
Expanding access to CFTR modulators for rare mutations: The utility of n-of-1 trialsAmalia S Magaret, Nicole Mayer-Hamblett, Donald VanDevanter
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Thorax|December 2, 2021
What shall we learn from TEACH?Donald VanDevanter, John Lipuma
Thorax|February 24, 2016
Advancing clinical development pathways for new CFTR modulators in cystic fibrosisNicole Mayer-Hamblett, Michael Boyle, Donald VanDevanter
Seminars in Respiratory and Critical Care Medicine|December 31, 2019
Cystic Fibrosis: Advances in Understanding and TreatmentPatrick A Flume, Christopher H Goss, Donald VanDevanter
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2019
Expanding access to CFTR modulators for rare mutations: The utility of n-of-1 trialsAmalia S Magaret, Nicole Mayer-Hamblett, Donald VanDevanter
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2025
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbationsRanjani Somayaji, Jonathan D Cogen, Donald VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Pageof 1